Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hills

Showing results (151-160 of 298) with videos related to

Pageof 30
Sort By:
Neurology|November 10, 2017
Population-based study of ischemic stroke risk after trauma in children and young adultsChristine K Fox, Nancy K Hills, David R Vinson, et al.
Leukemia|January 24, 2017
Clinical relevance of failed and missing cytogenetic analysis in acute myeloid leukaemiaL Chilton, C J Harrison, I Ashworth, et al.
Blood|May 21, 2011
The prognostic significance of IDH2 mutations in AML depends on the location of the mutationClaire L Green, Catherine M Evans, Lu Zhao, et al.
Facial Plastic Surgery & Aesthetic Medicine|January 18, 2024
Assessing the Prevalence of Craniomaxillofacial Injuries Among Helmeted and Unhelmeted Electric Scooter UsersTania Benjamin, Gaelen Stanford-Moore, Sonia Targ, et al.
Leukemia|February 14, 2015
A randomised comparison of the novel nucleoside analogue sapacitabine with low-dose cytarabine in older patients with acute myeloid leukaemiaA K Burnett, N Russell, R K Hills, et al.
British Journal of Haematology|May 30, 2012
The addition of the farnesyl transferase inhibitor, tipifarnib, to low dose cytarabine does not improve outcome for older patients with AMLAlan K Burnett, Nigel H Russell, Dominic Culligan, et al.
British Journal of Haematology|April 7, 2022
A randomised comparison of FLAG-Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trialNigel H Russell, Robert K Hills, Lars Kjeldsen, et al.
Molecular Phylogenetics and Evolution|June 19, 2018
Evolutionary lineages of marine snails identified using molecular phylogenetics and geometric morphometric analysis of shellsFelix Vaux, Steven A Trewick, James S Crampton, et al.
The American Journal of Cardiology|December 27, 2011
Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart diseaseAlexander Lowenthal, Benjamin Villareal Camacho, Shiri Lowenthal, et al.
Haematologica|October 14, 2017
Variable outcome and methylation status according to <i>CEBPA</i> mutant type in double-mutated acute myeloid leukemia patients and the possible implications for treatmentDima El-Sharkawi, Duncan Sproul, Christopher G Allen, et al.
Pageof 30

Showing results (151-160 of 298) with videos related to

Sort By:
Pageof 30
Neurology|November 10, 2017
Population-based study of ischemic stroke risk after trauma in children and young adultsChristine K Fox, Nancy K Hills, David R Vinson, et al.
Leukemia|January 24, 2017
Clinical relevance of failed and missing cytogenetic analysis in acute myeloid leukaemiaL Chilton, C J Harrison, I Ashworth, et al.
Blood|May 21, 2011
The prognostic significance of IDH2 mutations in AML depends on the location of the mutationClaire L Green, Catherine M Evans, Lu Zhao, et al.
Facial Plastic Surgery & Aesthetic Medicine|January 18, 2024
Assessing the Prevalence of Craniomaxillofacial Injuries Among Helmeted and Unhelmeted Electric Scooter UsersTania Benjamin, Gaelen Stanford-Moore, Sonia Targ, et al.
Leukemia|February 14, 2015
A randomised comparison of the novel nucleoside analogue sapacitabine with low-dose cytarabine in older patients with acute myeloid leukaemiaA K Burnett, N Russell, R K Hills, et al.
British Journal of Haematology|May 30, 2012
The addition of the farnesyl transferase inhibitor, tipifarnib, to low dose cytarabine does not improve outcome for older patients with AMLAlan K Burnett, Nigel H Russell, Dominic Culligan, et al.
British Journal of Haematology|April 7, 2022
A randomised comparison of FLAG-Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trialNigel H Russell, Robert K Hills, Lars Kjeldsen, et al.
Molecular Phylogenetics and Evolution|June 19, 2018
Evolutionary lineages of marine snails identified using molecular phylogenetics and geometric morphometric analysis of shellsFelix Vaux, Steven A Trewick, James S Crampton, et al.
The American Journal of Cardiology|December 27, 2011
Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart diseaseAlexander Lowenthal, Benjamin Villareal Camacho, Shiri Lowenthal, et al.
Haematologica|October 14, 2017
Variable outcome and methylation status according to <i>CEBPA</i> mutant type in double-mutated acute myeloid leukemia patients and the possible implications for treatmentDima El-Sharkawi, Duncan Sproul, Christopher G Allen, et al.
Pageof 30